Literature DB >> 10321468

Pain related behaviour during vincristine-induced neuropathy in rats.

N Authier1, F Coudore, A Eschalier, J Fialip.   

Abstract

The development of suitable animal models of neuropathic pain is essential to understand the pathophysiological mechanisms responsible for this condition. This study presents the alterations in nociception observed in rats suffering from a peripheral neuropathy induced by 10 daily repeated intravenous injections of vincristine at doses of 50 or 75 microg/kg (total dose 500 or 750 microg/ kg). The rats present both mechanical hyperalgesia, allodynia and a loss of sensitivity (thermal hypoalgesia). Conservation of good health, the fast appearance of symptoms which correspond well with human responses and the easy induction of nociceptive symptoms are favourable criteria for using this model at 50 microg/kg vincristine dose in the future.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10321468     DOI: 10.1097/00001756-199904060-00013

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

1.  Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells.

Authors:  Chiang Siau; Wenhua Xiao; Gary J Bennett
Journal:  Exp Neurol       Date:  2006-06-22       Impact factor: 5.330

Review 2.  Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics.

Authors:  Holly L Hopkins; Natalie A Duggett; Sarah J L Flatters
Journal:  Curr Opin Support Palliat Care       Date:  2016-06       Impact factor: 2.302

3.  Vincristine-induced neuropathy in rat: electrophysiological and histological study.

Authors:  Feras M H Ja'afer; Farqad B Hamdan; Faiq H Mohammed
Journal:  Exp Brain Res       Date:  2006-05-31       Impact factor: 1.972

4.  Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat.

Authors:  O A Dina; J Barletta; X Chen; A Mutero; A Martin; R O Messing; J D Levine
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

5.  Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.

Authors:  E J Rahn; A Makriyannis; A G Hohmann
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

6.  Neuroprotective Effect of Matrine in Mouse Model of Vincristine-Induced Neuropathic Pain.

Authors:  Shuai-Shuai Gong; Yu-Xiang Li; Meng-Ting Zhang; Juan Du; Peng-Sheng Ma; Wan-Xia Yao; Ru Zhou; Yang Niu; Tao Sun; Jian-Qiang Yu
Journal:  Neurochem Res       Date:  2016-08-25       Impact factor: 3.996

Review 7.  The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.

Authors:  Giulia Donvito; Sara R Nass; Jenny L Wilkerson; Zachary A Curry; Lesley D Schurman; Steven G Kinsey; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

Review 8.  Animal models of cancer pain.

Authors:  Cholawat Pacharinsak; Alvin Beitz
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

Review 9.  Animal models of chemotherapy-evoked painful peripheral neuropathies.

Authors:  Nicolas Authier; David Balayssac; Fabien Marchand; Bing Ling; Aude Zangarelli; Juliette Descoeur; François Coudore; Emmanuel Bourinet; Alain Eschalier
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Structural and molecular alterations of primary afferent fibres in the spinal dorsal horn in vincristine-induced neuropathy in rat.

Authors:  Karine Thibault; Isabelle Rivals; Saïd M'Dahoma; Sophie Dubacq; Sophie Pezet; Bernard Calvino
Journal:  J Mol Neurosci       Date:  2013-08-23       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.